Bone marrow mesenchymal stem cells derived cytokines associated with AKT/IAPs signaling ameliorate Alzheimer’s disease development
Abstract Background Alzheimer’s disease (AD) is a progressive neurodegenerative condition affecting around 50 million people worldwide. Bone marrow-derived mesenchymal stem cells (BMMSCs) have emerged as a promising source for cellular therapy due to their ability to differentiate into multiple cell...
Saved in:
Main Authors: | Yalan Lu, Yanfeng Xu, Li Zhou, Siyuan Wang, Yunlin Han, Kewei Wang, Chuan Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-025-04131-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS
by: Maria Teresa Voso, et al.
Published: (2023-08-01) -
Increase of circulating IGFBP-4 following genotoxic stress and its implication for senescence
by: Nicola Alessio, et al.
Published: (2020-03-01) -
Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway
by: Hei-Yin Tam, et al.
Published: (2025-01-01) -
Human epicardial organoids from pluripotent stem cells resemble fetal stage with potential cardiomyocyte- transdifferentiation
by: Fanwen Wang, et al.
Published: (2025-01-01) -
High paracrine activity of hADSCs cartilage microtissues inhibits extracellular matrix degradation and promotes cartilage regeneration
by: Wei Liu, et al.
Published: (2025-02-01)